QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
Free Trial
OTCMKTS:GNWSF

StageZero Life Sciences (GNWSF) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free GNWSF Stock Alerts
$0.04
0.00 (0.00%)
(As of 04/18/2024 ET)
Compare
Today's Range
$0.04
▼
$0.04
50-Day Range
$0.03
▼
$0.04
52-Week Range
$0.00
▼
$1.27
Volume
N/A
Average Volume
26,719 shs
Market Capitalization
$2.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartFinancialsHeadlinesSEC Filings
GNWSF stock logo

About StageZero Life Sciences Stock (OTCMKTS:GNWSF)

StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.

GNWSF Stock Price History

GNWSF Stock News Headlines

April 19, 2024 | bizjournals.com
New report shows sustained growth for Washington's life science industry
April 4, 2024 | theglobeandmail.com
StageZero Life Sciences: Top 10 Undervalued Healthcare Sector Stocks on TSX (SZLS)
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 5, 2024 | msn.com
Life Below Zero Season 9 Streaming: Watch & Stream Online via Disney Plus
February 15, 2024 | bizjournals.com
Wu awards $4.7 million to train Bostonians in life sciences industry
February 3, 2024 | msn.com
What Is the Sandwich Generation? Here’s What You Need to Know About This Growing Cohort
November 15, 2023 | finance.yahoo.com
StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
October 26, 2023 | bizjournals.com
In life sciences, Boston continues to reign supreme
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
October 5, 2023 | bizjournals.com
New York City life-science market ranks among top 10 in country
October 3, 2023 | bizjournals.com
Syneos Health replaces CEO with life sciences veteran Colin Shannon days after $7B deal closes
September 12, 2023 | markets.businessinsider.com
Sustainability, equipment upgrades, and digitalization: big priorities for global pharmaceuticals, life science global study finds
September 11, 2023 | msn.com
Report: Mass. life sciences grew in 'toughest times' in Worcester, Suffolk counties
June 29, 2023 | finance.yahoo.com
Canadian Investment Regulatory Organization Trading Halt - SZLS.WT
June 20, 2023 | finance.yahoo.com
StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024
June 5, 2023 | finance.yahoo.com
StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call
May 29, 2023 | msn.com
5 innovators to watch in R.I.’s life sciences industry
May 16, 2023 | msn.com
StageZero Life Sciences Ltd. GAAP EPS of -$0.02, revenue of $0.8M
May 12, 2023 | technews.tmcnet.com
Life Science Instrumentation Market worth $73.9 billion | MarketsandMarkets
April 6, 2023 | bizjournals.com
Demand outstripping construction in L.A.'s life-science real estate market
March 31, 2023 | finance.yahoo.com
StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update
January 25, 2023 | forbes.com
It's Time For The Life Sciences Industry To Embrace Quality 4.0
January 17, 2023 | nytimes.com
What Happened to All of Science’s Big Breakthroughs?
December 10, 2022 | theglobeandmail.com
StageZero Life Sciences: Bottom 25 Performing Stocks Year-to-Date on TSX (SZLS)
August 18, 2022 | finance.yahoo.com
StageZero Life Sciences Announces Closing of Convertible Debenture Financing
August 17, 2022 | finanznachrichten.de
StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q2 2022 Financial Results and Operational Update
August 16, 2022 | seekingalpha.com
StageZero Life Sciences Ltd. (SZLSF) CEO James Howard-Tripp on Q2 2022 Results - Earnings Call Transcript
See More Headlines
Receive GNWSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNWSF
CUSIP
N/A
CIK
1454263
Web
www.stagezerolifesciences.com
Phone
905-209-2030
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-6,860,000.00
Net Margins
-200.26%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-165.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.15
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$4.15 million
Price / Sales
0.59
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-1.95

Miscellaneous

Outstanding Shares
62,995,000
Free Float
N/A
Market Cap
$2.46 million
Optionable
Not Optionable
Beta
0.28
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. James R. Howard-Tripp
    Exec. Chairman & CEO
  • Mr. Carl Solomon
    Interim Chief Financial Officer
  • Prof. Choong-Chin Liew
    Co-Founder
  • Mr. Warren Whitehead C.M.A. (Age 69)
    Chief Accountant
  • Mr. David Suria
    Sr. Scientist

Key Competitors

View All Competitors

GNWSF Stock Analysis - Frequently Asked Questions

How have GNWSF shares performed in 2024?

StageZero Life Sciences' stock was trading at $0.0294 at the beginning of 2024. Since then, GNWSF shares have increased by 32.7% and is now trading at $0.0390.
View the best growth stocks for 2024 here.

How do I buy shares of StageZero Life Sciences?

Shares of GNWSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GNWSF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends